KURA
KURA
NASDAQ · Biotechnology

Kura Oncology Inc

$11.73
+0.01 (+0.09%)
As of Sep 20, 10:21 PM ET ·
Financial Highlights (FY 2026)
Revenue
65.52M
Net Income
-270,542,124
Gross Margin
99.9%
Profit Margin
-413.0%
Rev Growth
D/E Ratio
0.06
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 99.9% 56.8% 56.8% 56.8%
Operating Margin -449.9% 21.2% 23.8% 19.3%
Profit Margin -413.0% 14.6% 17.9% 18.5%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 65.52M 146.41M 142.51M 137.24M
Gross Profit 65.46M 83.09M 80.88M 77.89M
Operating Income -294,782,996 31.11M 33.93M 26.49M
Net Income -270,542,124 21.31M 25.50M 25.40M
Gross Margin 99.9% 56.8% 56.8% 56.8%
Operating Margin -449.9% 21.2% 23.8% 19.3%
Profit Margin -413.0% 14.6% 17.9% 18.5%
Rev Growth -6.0% +22.0% -9.5%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 26.56M 192.12M 161.82M 186.45M
Total Equity 476.06M 502.37M 476.57M 529.75M
D/E Ratio 0.06 0.38 0.34 0.35
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -293,771,090 41.90M 41.44M 41.75M
Free Cash Flow 24.20M 22.28M 20.94M